1-2 of 2
Keywords: Sodium-glucose cotransporter 2 inhibitor
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles
Journal Articles
Cardiorenal Med (2022) 12 (3): 81–93.
Published Online: 14 July 2022
...Jennifer B. Green; Peter A. McCullough Introduction: Cardiovascular (CV) disease and chronic kidney disease (CKD) share common risk factors, including type 2 diabetes mellitus (T2DM). In CV outcome studies of patients with T2DM, sodium-glucose cotransporter 2 inhibitor (SGLT2i) therapy...